Track the Oncimmune Holdings plc share price and the full insider trade history of the company, a publicly traded company based in United Kingdom. Shares trade on the UK market, under the authority of RNS (LSE). The latest transaction was reported on 11 November 2024 (Purchase). Among the most active insiders: Martin Gouldstone. The full history is openly available.
9
Insider Decl.
n/a
Thresholds
€112,882
5 ops.
Buy Volume
n/a
n/a
Sell Volume
30Σ signal
Buys €112,882n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
48,370 shares@ £0.2065100.0% of flowLondon Stock Exchange, AIMXRNS:4792314
9 of 9 declarations
Acerca de Oncimmune Holdings plc
Oncimmune Holdings plc es una empresa de biotecnología centrada en el desarrollo de pruebas diagnósticas para el cáncer. Se especializa en la identificación de biomarcadores inmunes para mejorar la detección y el tratamiento del cáncer.